Showing 231-240 of 3135 results for "".
Octane Aesthetics Tech Forum: Perfect Corp. Chief Growth Officer Wayne Liu Talks Revolutionary Artificial Intelligence Innovations
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-perfect-corp-chief-growth-officer-wayne-liu-talks-revolutionary-artificial-intelligence-innovations/33863/Wayne Liu, Chief Growth Officer and President of the Americas for Perfect Corp., sat down with Modern Aesthetics to discuss the latest innovations for artificial intelligence in aesthetic medicine.Octane Aesthetic Tech Forum: Dr. Jason Bloom Dives into Why He’s Held Out on Partnering with Private Equity Firm
https://modernaesthetics.com/conferences/octane-atf/voctane-aesthetic-tech-forum-dr-jason-bloom-dives-into-why-hes-held-out-on-partnering-with-private-equity-firm/33857/Jason Bloom, MD, FACS, is on Octane’s medical aesthetics advisory board. At this year’s forum, Dr. Bloom was part of the Private Equity in Aesthetics Debate. He shared where he stands with Modern Aesthetics.MATV News: DenfenAge Skincare Product Wins Beauty Award; Aerolase Art of Diversity Conference Sees Record Attendance; and More
https://beta.modernaesthetics.com/series/matv-news/matv-news-denfenage-skincare-product-wins-beauty-award-aerolase-art-of-diversity-conference-sees-record-attendance-and-more/33817/In this week’s episode of MATV News, DefenAge Skincare celebrates receiving a beauty award; the Aerolase Art of Diversity Conference sees a record attendance; a member of the British Parliament calls for BBL procedures to be suspended; and Epicutus launches a new product.MATV News: Endo Pulls Qwo from Market; Merz Aesthetics Adds SaltFacial; Current Trends in Aesthetic Medicine
https://beta.modernaesthetics.com/series/matv-news/matv-news-endo-pulls-qwo-from-market-merz-aesthetics-adds-saltfacial-current-trends-in-aesthetic-medicine/33713/Endo International is ceasing the production and sale of Endo Aesthetics' injectable cellulite treatment Qwo; Merz Aesthetics is adding the SaltFacial to its portfolio through an extended commercial agreement with SaltMED; and New York City dermatologist Dr. Robert Finney discusses trends in aesthetMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://beta.modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://beta.modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: AIS Meeting Highlights; Benefits of Allergan Aesthetics’ Loyalty Program; A Lack of Diversity in Aesthetic Clinical Trials
https://beta.modernaesthetics.com/series/matv-news/matv-news-ais-meeting-highlights-benefits-of-allergan-aesthetics-loyalty-program-a-lack-of-diversity-in-aesthetic-clinical-trials/33671/Physician and industry experts share highlights from the Aesthetics Innovation Summit; Allergan Aesthetics enhances its loyalty program with the launch of Alle Flash; and a new study shows a lack of ethnic/racial diversity in industry-sponsored aesthetic trials.MATV News: Revance Wins FDA Nod For Redensity Filler; Obagi Introduces Skintrinsiq, Aesthetic Physicians Cope with Covid-19
https://beta.modernaesthetics.com/series/matv-news/matv-news-revance-wins-fda-nod-for-redensity-filler-obagi-introduces-skintrinsiq-aesthetic-physicians-cope-with-covid-19/33656/FDA Approves Revance’s RHA Redensity filler for perioral rhytids, Obagi enters the device market with introduction of Skintrinsiq, and aesthetic physicians discuss how they’re coping with the recent COVID-19 surge.MATV News: Sciton’s BBlink Glasses; Crown to Acquire StriVectin; COVID Impact on Aesthetic Meetings: Galderma Planks for Pink
https://beta.modernaesthetics.com/series/matv-news/matv-news-scitons-bblink-glasses-crown-to-acquire-strivectin-covid-impact-on-aesthetic-meetings-galderma-planks-for-pink/33645/Sciton has introduced new smart goggles designed for provider comfort, Crown Laboratories is set to expand its skincare offerings through acquisition of StriVectin, aesthetic physicians and associations work to make meetings safe amid COVID concerns, and Galderma partners with the National Breast CaMATV News: AI Algorithms Estimate Facelift Success; Restylane Contour Approved for Cheeks; Mentor Joins Galderma ASPIRE Program
https://beta.modernaesthetics.com/series/matv-news/matv-news-ai-algorithms-estimate-facelift-success-restylane-contour-approved-for-cheeks-mentor-joins-galderma-aspire-program/33637/AI algorithms may provide an objective and reliable estimate of the apparent reduction in age after facelift surgery, Restylane Contour is now approved for cheek augmentation, and Mentor joins the ASPIRE Galderma rewards program.